Lymphocyte Targeting by Peptide-Drug Conjugates

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43AI052556-01A1
Agency Tracking Number: AI052556
Amount: $100,000.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solicitation Year: 2004
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Small Business Information
ADMUNEX THERAPEUTICS, INC.
ADMUNEX THERAPEUTICS, INC., 3514 CLINTON PKY, STE A-111, LAWRENCE, KS, 66047
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 LEO Gu
 (408) 245-0003
 IGU@ADMUNEX.COM
Business Contact
 THOMAS MALEFYT
Phone: (831) 659-4336
Email: tmalefyt@admunex.com
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The long-term objective of this work is to design bi-functional peptide-drug conjugates that specifically target leukocytes. The peptide sequences are derived from ICAM-1 and bind to LFA-1 on activated leukocytes. The

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government